Number of metastatic sites rather than location dictates overall survival of patients with node-negative metastatic renal cell carcinoma
- 1 February 2003
- Vol. 61 (2) , 314-319
- https://doi.org/10.1016/s0090-4295(02)02163-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell CancerNew England Journal of Medicine, 2001
- Nephrectomy and Interleukin-2 for Metastatic Renal-Cell CarcinomaNew England Journal of Medicine, 2001
- Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trialThe Lancet, 2001
- Surgical Management of Renal Cell Carcinoma With Inferior Vena Cava Tumor ThrombusThe Annals of Thoracic Surgery, 1997
- Prognostic factors for survival in patients with advanced renal cell carcinoma treated with interleukin-2 and interferon-?Zeitschrift für Krebsforschung und Klinische Onkologie, 1995
- Prognostic Factors for Survival in Patients with Metastatic Renal Cancer Treated with Biological Response ModifiersJournal of Urology, 1995
- Renal cell carcinoma extending to the renal vein and inferior vena cava: Results of surgical treatment and prognostic factorsJournal of Surgical Oncology, 1995
- Prognostic significance of morphologic parameters in renal cell carcinomaThe American Journal of Surgical Pathology, 1982
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958